Literature DB >> 8988736

Gangliogliomas in adults.

R Hakim1, J S Loeffler, D C Anthony, P M Black.   

Abstract

BACKGROUND: Gangliogliomas are rare tumors occurring in both children and adults that are characterized by the presence of neoplastic cells resembling both neurons and glia.
METHODS: The authors reviewed 18 adults patients with intracranial gangliogliomas treated at the study institutions between October 1987 and November 1995.
RESULTS: The median age at diagnosis was 33.7 years, with a range of 21 to 55 years. Median follow-up was 37.7 months, with a range of 4 months to 13 years. Clinical manifestations among the patients included seizures (13), headache (2), ataxia (1), and hemiparesis and paresthesias (1 patient each). Tumors were located in the temporal lobe (6 patients), temporal lobe and thalamus (1 patient), frontal lobe (5 patients), cerebellum (4 patients), and insula or thalamus (1 patient each). Thirteen patients underwent gross total resection, 4 underwent incomplete resection, and 1 underwent only a stereotactic biopsy. Treatment modalities included surgery only, surgery plus radiation, and surgery plus radiation and chemotherapy. Median survival was 90.3 months, with a range of 14 months to 13 years. Three patients were dead at follow-up with a mean survival of 32.3 months. These patients showed anaplastic features in their pathology at initial surgery or surgery for recurrence.
CONCLUSIONS: In adults, gangliogliomas have a relatively favorable prognosis; however, the presence of anaplastic features predicts a worse outcome.

Entities:  

Mesh:

Year:  1997        PMID: 8988736

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Optic pathway ganglioglioma with intraventricular cyst.

Authors:  Pietro Spennato; Mario Giordano; Claudio Ruggiero; Ferdinando Aliberti; Maria Consiglio Buonocore; Anna Nastro; Vittoria D'Onofrio; Delfina Bifani; Giuseppe Cinalli
Journal:  J Neurooncol       Date:  2010-08-20       Impact factor: 4.130

2.  Evidence for clonal origin of neoplastic neuronal and glial cells in gangliogliomas.

Authors:  J J Zhu; S P Leon; R D Folkerth; S Z Guo; J K Wu; P M Black
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

3.  Survivin expression in ganglioglioma.

Authors:  Audrey Rousseau; Michèle Kujas; Anne-Marie Bergemer-Fouquet; Rémy van Effenterre; Jean-Jacques Hauw
Journal:  J Neurooncol       Date:  2005-11-15       Impact factor: 4.130

Review 4.  Malignant ganglioglioma: case report and review of literature.

Authors:  Ryan DeMarchi; Suzy Abu-Abed; David Munoz; R Loch Macdonald
Journal:  J Neurooncol       Date:  2010-06-04       Impact factor: 4.130

5.  Impact of surgery, adjuvant treatment, and other prognostic factors in the management of anaplastic ganglioglioma.

Authors:  Supriya Mallick; Rony Benson; Wineeta Melgandi; Prashanth Giridhar; G K Rath
Journal:  Childs Nerv Syst       Date:  2018-03-29       Impact factor: 1.475

6.  Intracranial ganglioglioma WHO I: results in a series of eight patients treated with stereotactic interstitial brachytherapy.

Authors:  Faycal El Majdoub; Essam Rezk; Stefan Hunsche; Christian Bührle; Volker Sturm; Mohammad Maarouf
Journal:  J Neurooncol       Date:  2014-04-27       Impact factor: 4.130

7.  Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall.

Authors:  Arie Perry; Stephanie S Burton; Gregory N Fuller; Christopher A Robinson; Cheryl A Palmer; Lothar Resch; Eileen H Bigio; Meena Gujrati; Marc K Rosenblum
Journal:  Acta Neuropathol       Date:  2010-05-13       Impact factor: 17.088

8.  Cerebellar ganglioglioma.

Authors:  Seong-Ho Park; Ealmaan Kim; Eun-Ik Son
Journal:  J Korean Neurosurg Soc       Date:  2008-03-20

9.  Spinal cord gangliogliomas: a review of 56 patients.

Authors:  George I Jallo; Diana Freed; Fred J Epstein
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

10.  A Rare Case of a Congenital Nasopharyngeal Ganglioglioma With Dyspnea in a 1-Month-Old Male Infant: A Case Report.

Authors:  He Zhao; Zhiwei Cao; Zhaowei Gu
Journal:  Front Pediatr       Date:  2021-06-10       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.